Physician

Avtar T Ghuman, MD

According to 2025 Medicare claims, Avtar Ghuman, MD (NPI: 1801883822) practices ophthalmology in the Cape Coral-Fort Myers, FL market, with the plurality of this provider's patient population coming from Lee, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34103-9998.

Ghuman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 939 traditional Medicare patients, billed 51,230 HCPCS/CPT codes, and received $3,328,952 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 318 prescription claims across 93 beneficiaries totaling $403,679 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 8 records totaling $241. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $30,258 to $403,679. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.1M2015 Medicare payment: $3,992,899 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,120,482 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,637,568 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,538,385 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,774,273 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,852,232 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,839,287 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,549,755 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,269,869 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,328,952 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,01421,807$3,992,899
20162,23623,289$4,120,482
20172,00119,039$3,637,568
20181,88717,492$3,538,385
20191,87317,717$3,774,273
20201,58717,587$3,852,232
20211,55016,814$3,839,287
20221,23115,784$3,549,755
20231,00836,083$3,269,869
202493951,230$3,328,952

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$202K$404K2015 Drug cost: $30,258 (USD; Tot_Drug_Cst)2016 Drug cost: $41,129 (USD; Tot_Drug_Cst)2017 Drug cost: $33,083 (USD; Tot_Drug_Cst)2018 Drug cost: $40,652 (USD; Tot_Drug_Cst)2019 Drug cost: $39,500 (USD; Tot_Drug_Cst)2020 Drug cost: $27,426 (USD; Tot_Drug_Cst)2021 Drug cost: $38,020 (USD; Tot_Drug_Cst)2022 Drug cost: $250,683 (USD; Tot_Drug_Cst)2023 Drug cost: $216,978 (USD; Tot_Drug_Cst)2024 Drug cost: $403,679 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015125386$30,258
2016136443$41,129
2017103317$33,083
2018132441$40,652
2019106334$39,500
202089258$27,426
202182283$38,020
202274296$250,683
202362270$216,978
202493318$403,679

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2342,390$659
67028Injection of drug into eye3992,114$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more548648$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4681,114$71
92134Imaging of retina8892,593$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept992,968$233,970
VabysmoFaricimab-Svoa531,540$122,359
ProlensaBromfenac Sodium19513$6,639
Prednisolone AcetatePrednisolone Acetate431,572$1,721
Bromfenac SodiumBromfenac Sodium17541$1,669

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$241Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$60,887US Retina LLC

FAQ

What Medicare data is available for Avtar T. Ghuman, MD?

Tedicare shows public-source Medicare data for Avtar T. Ghuman, MD (NPI 1801883822), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Avtar T. Ghuman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Avtar T. Ghuman, MD?

Avtar T. Ghuman, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Avtar T. Ghuman, MD have Open Payments data?

Avtar T. Ghuman, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.